B-non Hodgkin lymphoma

Clinical trials for B-non Hodgkin lymphoma explained in plain language.

Never miss a new study

Get alerted when new B-non Hodgkin lymphoma trials appear

Sign up with your email to follow new studies for B-non Hodgkin lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Completed 1

New Dual-Target CAR T-Cell therapy aims to beat relapsed childhood cancers

Disease control Recruiting now

This study tests a new type of CAR T-cell therapy that targets two proteins, CD19 and CD22, on cancer cells. It is for children and young adults aged 3 to 39 with B-cell cancers like leukemia or lymphoma that have not been cured by standard treatments. Participants receive their …

Matched conditions: B-NON HODGKIN LYMPHOMA

Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC

B-non Hodgkin lymphoma

Get alerted when new B-non Hodgkin lymphoma trials appear

New Dual-Target CAR T-Cell therapy aims to beat relapsed childhood cancers